| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| H3P8 |
|
H3 histone pseudogene 8
|
|
|
0.544 |
0.808 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| DCR |
|
Down syndrome chromosome region
|
|
|
0.674 |
0.538 |
| FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
| DEL11P13 |
|
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome
|
|
|
0.716 |
0.538 |
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
| MBS1 |
|
Moebius syndrome 1
|
|
|
0.805 |
0.308 |
| XIC |
|
X chromosome inactivation center
|
|
|
0.821 |
0.462 |
| MRX49 |
|
mental retardation, X-linked 49
|
|
|
0.821 |
0.385 |
| MEHMO |
|
mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome
|
|
|
0.890 |
0.269 |
| ENFL2 |
|
Epilepsy, nocturnal frontal lobe, type 2
|
|
|
0.839 |
0.346 |
| GDI2P1 |
|
GDP dissociation inhibitor 2 pseudogene 1
|
|
|
0.931 |
0.192 |
| FRA12A |
|
fragile site, folic acid type, rare, fra(12)(q13.1)
|
|
|
1.000 |
0.192 |
| MACROD2 |
A1Z1Q3
|
mono-ADP ribosylhydrolase 2
|
|
0.43 |
0.686 |
0.423 |
| SFI1 |
A8K8P3
|
SFI1 centrin binding protein
|
|
5.9E-44 |
0.792 |
0.423 |
| HEPACAM2 |
A8MVW5
|
HEPACAM family member 2
|
|
1.6E-10 |
0.890 |
0.308 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| LAD1 |
O00515
|
ladinin 1
|
Cellular structure
|
1.8E-14 |
0.584 |
0.731 |
| CHL1 |
O00533
|
cell adhesion molecule L1 like
|
|
8.9E-12 |
0.603 |
0.654 |
| PEX7 |
O00628
|
peroxisomal biogenesis factor 7
|
|
8.2E-13 |
0.603 |
0.615 |
| VCY |
O14598
|
variable charge Y-linked
|
|
|
0.890 |
0.231 |